Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Yang

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2024
Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal CancerEmily Harrold, Fergus Keane, Henry Walch, et al.
Biomolecules|September 11, 2020
Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination TherapyArchana P Thankamony, Reshma Murali, Nitheesh Karthikeyan, et al.
Breast Cancer Research : BCR|June 14, 2015
MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor geneYu Wei Phua, Akira Nguyen, Daniel L Roden, et al.
Mabs|December 29, 2021
Multi-attribute Raman spectroscopy (MARS) for monitoring product quality attributes in formulated monoclonal antibody therapeuticsBingchuan Wei, Nicholas Woon, Lu Dai, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective studyYana G Najjar, Kristina Navrazhina, Fei Ding, et al.
Breast Cancer Research : BCR|August 4, 2021
Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived modelsNicole J Chew, Terry C C Lim Kam Sian, Elizabeth V Nguyen, et al.
Nature Communications|March 28, 2015
ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotypeSimon Junankar, Laura A Baker, Daniel L Roden, et al.
Frontiers in Cell and Developmental Biology|August 9, 2020
Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1Wee S Teo, Holly Holliday, Nitheesh Karthikeyan, et al.
Nature Communications|July 26, 2018
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancerAurélie S Cazet, Mun N Hui, Benjamin L Elsworth, et al.
The Lancet. Oncology|September 4, 2023
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trialSamuel L Cytryn, Ryan H Moy, Darren Cowzer, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2024
Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal CancerEmily Harrold, Fergus Keane, Henry Walch, et al.
Biomolecules|September 11, 2020
Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination TherapyArchana P Thankamony, Reshma Murali, Nitheesh Karthikeyan, et al.
Breast Cancer Research : BCR|June 14, 2015
MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor geneYu Wei Phua, Akira Nguyen, Daniel L Roden, et al.
Mabs|December 29, 2021
Multi-attribute Raman spectroscopy (MARS) for monitoring product quality attributes in formulated monoclonal antibody therapeuticsBingchuan Wei, Nicholas Woon, Lu Dai, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective studyYana G Najjar, Kristina Navrazhina, Fei Ding, et al.
Breast Cancer Research : BCR|August 4, 2021
Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived modelsNicole J Chew, Terry C C Lim Kam Sian, Elizabeth V Nguyen, et al.
Nature Communications|March 28, 2015
ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotypeSimon Junankar, Laura A Baker, Daniel L Roden, et al.
Frontiers in Cell and Developmental Biology|August 9, 2020
Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1Wee S Teo, Holly Holliday, Nitheesh Karthikeyan, et al.
Nature Communications|July 26, 2018
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancerAurélie S Cazet, Mun N Hui, Benjamin L Elsworth, et al.
The Lancet. Oncology|September 4, 2023
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trialSamuel L Cytryn, Ryan H Moy, Darren Cowzer, et al.
Pageof 7